These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer. Onodera H, Tokunaga A, Yoshiyuki T, Kiyama T, Kato S, Matsukura N, Masuda G, Tajiri T. Hepatogastroenterology; 2004; 51(55):82-5. PubMed ID: 15011835 [Abstract] [Full Text] [Related]
4. Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer. Reis E, Kama NA, Doganay M, Atli M, Dolapci M. Hepatogastroenterology; 2002; 49(46):1167-71. PubMed ID: 12143228 [Abstract] [Full Text] [Related]
5. Evaluation of surgical treatment for patients with gastric cancer who are over 80 years of age. Kitamura K, Sugimachi K, Saku M. Hepatogastroenterology; 1999; 46(27):2074-80. PubMed ID: 10430400 [Abstract] [Full Text] [Related]
6. Gastrectomy circumstances that influence early postoperative outcome. Schwarz RE, Zagala-Nevarez K. Hepatogastroenterology; 2002; 49(48):1742-6. PubMed ID: 12397783 [Abstract] [Full Text] [Related]
7. Effect of age on surgical outcomes of extended gastrectomy with D2 lymph node dissection in gastric carcinoma: prospective cohort study. Jeong O, Park YK, Ryu SY, Kim YJ. Ann Surg Oncol; 2010 Jun; 17(6):1589-96. PubMed ID: 20099039 [Abstract] [Full Text] [Related]
8. Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer. Yamamoto M, Baba H, Kakeji Y, Endo K, Ikeda Y, Toh Y, Kohnoe S, Okamura T, Maehara Y. Hepatogastroenterology; 2004 Jun; 51(55):298-302. PubMed ID: 15011889 [Abstract] [Full Text] [Related]
14. [Lymph node excision in stomach cancer--a statistical analysis of survival and surgical mortality]. Hassdenteufel A, Junginger T. Zentralbl Chir; 1995 Jun; 120(10):791-4. PubMed ID: 7502594 [Abstract] [Full Text] [Related]
15. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M. J Clin Oncol; 2004 Jun 01; 22(11):2069-77. PubMed ID: 15082726 [Abstract] [Full Text] [Related]
16. [D3 versus D2 dissection in stomach carcinoma. A case-control study of postoperative morbidity, survival and early oncologic outcome]. Bittorf BR, Günther F, Merkel S, Horbach T, Hohenberger W, Günther K. Chirurg; 2002 Apr 01; 73(4):336-47. PubMed ID: 12063918 [Abstract] [Full Text] [Related]
19. Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients. Schmid A, Thybusch A, Kremer B, Henne-Bruns D. Hepatogastroenterology; 2000 Apr 01; 47(32):579-85. PubMed ID: 10791243 [Abstract] [Full Text] [Related]